Abstract: Plasmablastic lymphoma is a non-Hodgkin lymphoma characterized by its plasmacytic differentiation and predilection for the oral cavity. It is among the lymphomas most commonly associated with AIDS. This report details a case of a HIV-positive patient with a 1-month history of an exophytic mass in the gingival area of the upper left quadrant. The diagnosis of plasmablastic lymphoma was made based on its histopathological and immunophenotypical features. She was treated with chemotherapy followed by autologous hematopoietic stem cell transplantation. Despite complete resolution of the lesion, the patient died of cardiorespiratory arrest. This case illustrates plasmablastic lymphoma as the first clinical manifestation of AIDS, highlighting the importance of differentiating between a potentially malignant lesion and other pathologic processes.
INTRODUCTION
Plasmablastic lymphoma (PBL) is a non-Hodgkin lymphoma, variant of the diffuse large B-cell lymphoma, rare, aggressive and characterized by its plasmacytic differentiation. PBL occurs in patients with some form of immunosuppression, especially the one caused by HIV (human immunodeficiency virus) infection, and 80% of the cases associated with HIV are also positive for Epstein-Barr virus (EBV). [1] [2] [3] [4] It affects more men, with a 4:1 ratio and mean age of 39 years.
However, due to its rarity, the exact incidence remains unknown.
1,2,4
The clinical presentation is of an exophytic, painless, rapidly growing and sometimes ulcerated lesion. It has predilection for the mouth, particularly the gingivae and palate. Submandibular and cervical lymphadenopathy, as well as B-cell lymphoma symptoms like fever, night sweats and weight loss can be present. 1, 5, 6 The differential diagnosis of an expanding oral lesion includes from infectious dental processes to malignancies. Malignancies include squamous cell carcinoma, metastatic tumors and Kaposi sarcoma. Besides plasmablastic lymphoma, other types of lymphoma can also occur in the oral cavity, including diffuse large B-cell lymphoma, plasmacytomas and Burkitt lymphoma.
5
There is no standard treatment for plasmablastic lymphoma.
However, chemotherapy remains as the treatment of choice. Recently, autologous hematopoietic stem cell transplantation has been shown to be an option, increasing patient survival.
1,2,5
CASE REPORT Fifty-six-year-old female Caucasian pacient, smoker, was referred for the diagnosis of a lesion on the gingiva. When the lesion first appeared, 1 month one month before the appointement, the patient sought a dental surgeon that upon noticing intense bone loss on the right posterior maxillary region on the radiograph, suggestive of periodontal destruction, opted to We collected a detailed history and on physical examination a painless tumor with an erythematous surface and an ulcerated area was observed on the right upper gingiva (Figure 1 ). The radiograph showed intense, generalized periodontal bone loss. Incisional biopsy was performed, and the sample was sent to the laboratory for analysis.
Histopathology showed a fragment of lymphoid neoplasia, represented by a layer of bulky cells, similar to immunoblasts.
Intense pleomorphism and multiple mitotic figures were also ob- 
DISCUSSION
With the advent of HAART, the incidence of opportunistic infections as well as the morbidity and mortality associated to HIV infection decreased, a trend that could also be seen with oral lesions. 7, 8 The incidence of lymphomas associated with HIV infection in general decreased 50% after HAART was made avail-
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